Magnetic labeling of pancreatic β-cells modulates the glucose- and insulin-induced phosphorylation of ERK1/2 and AKT

Authors

  • Hoe Suk Kim,

    1. Department of Radiology, Seoul National University Hospital, Seoul, Korea
    2. Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea
    Search for more papers by this author
    • These authors contributed equally to this work
  • Lianji Tian,

    1. Department of Radiology, Seoul National University Hospital, Seoul, Korea
    2. Department of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea
    Search for more papers by this author
    • These authors contributed equally to this work
  • Shunmei Lin,

    1. Department of Radiology, Seoul National University Hospital, Seoul, Korea
    Search for more papers by this author
  • Joo Hee Cha,

    1. Department of Radiology, Seoul National University Hospital, Seoul, Korea
    Search for more papers by this author
  • Hye Seung Jung,

    1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
    Search for more papers by this author
  • Kyong Soo Park,

    1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
    Search for more papers by this author
  • Woo Kyung Moon

    Corresponding author
    1. Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea
    2. Department of Biomedical Science, College of Medicine, Seoul National University, Seoul, Korea
    • Department of Radiology, Seoul National University Hospital, Seoul, Korea
    Search for more papers by this author

W. K. Moon, Department of Radiology, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 110-744, Korea. E-mail: moonwk@snu.ac.kr

Abstract

This study was undertaken to investigate the effect of a magnetic resonance imaging (MRI) contrast agent, superparamagnetic iron oxide nanoparticle (SPIO), on signal transduction by glucose and insulin in pancreatic β-cells. INS-1 cells were labeled in culture medium containing clinically approved SPIO for 24 h. Labeled and unlabeled cells were stimulated with glucose (25 mM) or insulin (0.1–1 µM) for 12 h. The phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2) and protein kinase B (AKT) and intracellular insulin protein levels were assessed by Western blotting. After labeling with increasing amounts of SPIO, cytotoxicity was not observed, yet the intracellular iron concentration increased in a dose-dependent manner. SPIO labeling (200 µg Fe ml−1) induced a significant increase in ERK1/2 and AKT phosphorylation (labeled vs unlabeled, p < 0.05), but significantly reduced the glucose-stimulated phosphorylation of ERK1/2 and AKT and insulin-stimulated phosphorylation of AKT (labeled vs unlabeled, p < 0.05). The level of intracellular insulin protein was found to be lower in labeled cells than unlabeled cells (labeled vs unlabeled, p < 0.05). This study demonstrates that SPIO labeling alters some fundamental functional variables, at least in INS-1 cells, through modulation of the glucose- or insulin-induced activation of ERK1/2 and AKT, which leads to insulin biosynthesis. Copyright © 2012 John Wiley & Sons, Ltd.

Ancillary